Across
- 2. Block inhibitory immune pathways
- 4. Drug administration
- 6. Drug breakdown
- 8. Antibody therapy
- 11. Immune signaling proteins
- 13. Progesterone hormone
- 16. Therapy failure
- 17. Gland/hormone target
- 18. Molecular communication
- 20. Cytotoxic innate cell
- 24. Female hormone
- 25. Drug elimination
- 26. Endocrine therapy
- 27. Reduced immune activity
- 30. Study of ADME
- 32. Drug binds protein
- 33. Therapy using immune system
- 35. Cytotoxic T-Lymphocyte Antigen 4
- 37. Safety margin
- 39. Drug activating receptor
- 40. Steroid hormone type
Down
- 1. Mineral-regulating steroid
- 3. Antibody-producing cell
- 5. Anti-inflammatory steroid
- 7. Fat-soluble drugs
- 9. Signaling molecule
- 10. Protein that drugs bind
- 12. Adverse effect
- 14. Preventive immune therapy
- 15. Fraction absorbed
- 19. Male hormone
- 21. Self-reactive immunity
- 22. Ligand for PD1
- 23. Multiple drugs
- 28. Activated in vivo
- 29. Immune response
- 31. Immune effector cell
- 34. Protein targeting antigen
- 36. Immune checkpoint receptor
- 38. Drug blocking receptor